November 1, 2021

The Covid-19 vaccine from Pfizer and BioNTech has been approved by the FDA for children aged 5 to 11.

The US Food and Drug Administration (FDA) approved the Pfizer-BioNTech Covid-19 (coronavirus disease 2019) vaccine for use in children aged 5 to 11 years old on Friday.

The FDA stated in a statement that the approval was based on a thorough and transparent review of the data, which includes feedback from independent advisory committee specialists who overwhelmingly voted in support of making the vaccine available to children in this age group.

The Pfizer-BioNTech vaccine is given in a two-dose primary series, 3 weeks apart, to children aged 5 to 11, although at a lower dose (10 micrograms) than the vaccination given to people aged 12 and up (30 micrograms).

The decision came after a meeting of FDA advisors earlier this week, which recommended that the vaccine be approved for children aged 5 to 11. For use in this younger age, FDA advisors believe the benefits of the Pfizer-BioNTech vaccine exceed the hazards.

It is the first Covid-19 vaccination for children aged 5 to 11 years old to be licensed for emergency use in the United States.

Please follow and like us:
Tweet 2k
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

Enjoy this blog? Please spread the word :)

Would love your thoughts, please comment.x